Reference : Abaloparatide for risk reduction of non-vertebral fractures in postmenopausal women w...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
http://hdl.handle.net/2268/223168
Abaloparatide for risk reduction of non-vertebral fractures in postmenopausal women with osteoporosis: an updated network meta-analysis.
English
Reginster, Jean-Yves mailto [Université de Liège - ULiège > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Bianic, F. []
Campbell, R. []
Martin, M. []
Williams, S.A. []
Fitzpatrick, L.A. []
Apr-2018
Osteoporosis International
Springer
29 S1
42
Yes (verified by ORBi)
No
International
0937-941X
1433-2965
Germany
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
19-22 avril 2018
WCO-IOF-ESCEO
Cracovie
Pologne
http://hdl.handle.net/2268/223168
10.1007/s00198-018-4470-4

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Abaloparatide for risk reduction of non-vertebral fractures in postmenopausal women with osteoporosis- an updated network meta-analysis..pdfPublisher postprint446.21 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.